06996 德琪醫藥－Ｂ
按盤價 
0.670 +0.020 (+3.077%) 盈利能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 資產回報率 (%) | -30.908% | -25.596% | -22.793% | -148.143% | -77.074% |
| 股東資金回報率 (%) | -40.632% | -29.286% | -24.135% | -236.185% | N/A |
| 資本運用回報率 (%) | -40.708% | -34.168% | -27.334% | -96.226% | -45.295% |
邊際利潤分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 毛利率 (%) | 81.735% | 82.433% | 84.080% | N/A | N/A |
| 未計利息、稅項、折舊及攤銷前利潤率 (%) | -875.260% | -375.632% | -2298.189% | N/A | N/A |
| 稅前邊際利潤率 (%) | -863.506% | -375.613% | -2278.595% | N/A | N/A |
| 純利率 (%) | -863.506% | -375.613% | -2278.595% | N/A | N/A |
變現能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 流動比率 (X) | 6.506 X | 4.966 X | 15.139 X | 20.770 X | 16.813 X |
| 速動比率 (X) | 6.426 X | 4.940 X | 15.123 X | 20.770 X | 16.813 X |
財務槓桿分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 總負債 / 總資產比率 (%) | 29.112% | 20.019% | 6.385% | 4.902% | 173.391% |
| 總債項 / 總資產比率 (%) | 12.419% | 2.705% | 0.579% | 0.342% | 0.548% |
| 淨債項 / 總資產比率 (%) | -60.960% | -80.838% | -88.361% | -97.011% | -97.743% |
| 總債項 / 股東資金比率 (%) | 17.520% | 3.383% | 0.619% | 0.360% | N/A |
| 長期債項 / 股東資金比率 (%) | 16.887% | 2.746% | 0.164% | 0.197% | N/A |
| 淨債項 / 股東資金比率 (%) | -85.994% | -101.071% | -94.388% | -102.011% | N/A |
| 淨現金 / (債項) ($) | 9.87億 | 17.32億 | 22.60億 | 30.99億 | 7.43億 |
| 每股淨現金 / (債項) ($) | 1.462 | 2.566 | 3.384 | 4.617 | -- |
| 總債項 / 資本運用比率 (%) | 14.080% | 3.292% | 0.618% | 0.359% | 0.583% |
| 利息盈利率 (X) | N/A | N/A | N/A | N/A | N/A |
營運效率分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 存貨周轉率日數 (日) | 373.492日 | 80.899日 | 205.452日 | N/A | -- |
| 應收貿易帳周轉率日數 (日) | 106.973日 | 41.909日 | 88.887日 | N/A | N/A |
| 應付貿易帳周轉率日數 (日) | 31.668日 | 10.595日 | 18.714日 | N/A | N/A |
| 備註： | 即時報價更新時間為29/11/2024 17:59 |
| 港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站 | |
| 股東應佔溢利/(虧損) () | RMB -167,033,000 |
| 增長率 | -23.623% |
| 每股盈利/(虧損) | RMB -0.270 |
| 每股帳面資產淨值 (¥) | RMB 1.472 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
